Search results
UPDATE 5-Shah Capital urges Novavax shareholders to vote against three directors
Reuters via Yahoo Finance· 1 day agoHedge fund Shah Capital on Monday urged Novavax shareholders to vote against the re-election of three directors and opposed proposals related to executive compensation, weeks after pushing for ...
BioNTech reports net loss of €315.1m in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 15 hours agoThis change is primarily due to the lower costs associated with decreased sales of the Covid-19 vaccine. These figures include the share ...
What's Going With BioNTech Stock On Monday?
Benzinga· 1 day agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
Study: Women can safely use hormone replacement therapy during menopause
UPI· 6 days agoHormone replacement therapy can safely ease middle-aged women's symptoms during early menopause,...
University of Minnesota strengthens case to treat COVID-19 with metformin, not ivermectin
Minneapolis-St. Paul Star Tribune· 5 days agoPatients with COVID-19 had lower viral loads if treated with metformin, according to new University...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 5 days agoIt lost $3.07 per share, flipping from a year-earlier gain of 19 cents. But that beat projections...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 6 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
GAO report shows SNS challenges during COVID, mpox
Center for Infectious Disease Research and Policy· 1 day agoIn fact, 35% of jurisdictions during COVID-19 and 30% during mpox said the process for requesting SNS inventory did not follow written guidelines.
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 5 days agoManagement expects to record around $0.3 billion in product sales in first...expects capital...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 5 days agoThe Spikevax story is over, but... Barring a renewed Covid surge -- fingers crossed! -- there isn't much future in Spikevax. Yet as ever, Moderna...
